Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Study design considerations for ribavirin: efficacy studies.

J T McBride1

  • 1Department of Pediatrics, University of Rochester Medical Center, NY 14642.

The Pediatric Infectious Disease Journal
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory synctial virus.

The Journal of infectious diseases·2002
Same author

Impact of low birth weight on early childhood asthma in the United States.

Archives of pediatrics & adolescent medicine·2001
Same author

Inadequate therapy for asthma among children in the United States.

Pediatrics·2000
Same author

Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

The Journal of clinical investigation·1999
Same author

Development of local guidelines for prevention of respiratory syncytial viral infections.

The Pediatric infectious disease journal·1999
Same author

Increase in admission threshold explains stable asthma hospitalization rates.

Pediatrics·1999
Same journal

A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings.

The Pediatric infectious disease journal·2026
Same journal

Model-based Differentiation Between Kawasaki Disease and MIS-C: The Importance of the Mitral Valve.

The Pediatric infectious disease journal·2026
Same journal

Pulmonary Embolism in Invasive Salmonella Infection: A Rare Cause of Acute Respiratory Failure in an Adolescent.

The Pediatric infectious disease journal·2026
Same journal

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same journal

Determinants of Severity in Pediatric Viral Lower Respiratory Tract Diseases From Emergency Department Presentation to Hospital Course.

The Pediatric infectious disease journal·2026
Same journal

Oropharyngeal Colonization by Kingella kingae and Septic Arthritis in Children 6-48 Months of Age: A Portuguese Multicenter Case-control Study.

The Pediatric infectious disease journal·2026
See all related articles

Aerosolized ribavirin shows a beneficial effect in treating respiratory syncytial virus (RSV) lower respiratory infections in infants. Studies confirm this statistically significant and clinically relevant impact, supporting its use.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Respiratory Syncytial Virus (RSV) is a common cause of lower respiratory infection in infants.
  • Effective treatments for RSV infection are crucial for reducing infant morbidity and mortality.

Purpose of the Study:

  • To evaluate the efficacy of aerosolized ribavirin in treating RSV lower respiratory infection in infants.
  • To determine the clinical relevance and statistical significance of ribavirin's therapeutic effect.

Main Methods:

  • Conducted five placebo-controlled, double-blind studies.
  • Each study included approximately 30 infants with RSV lower respiratory infection.
  • Utilized oximetry and an analog illness severity scale to measure treatment outcomes.

Related Experiment Videos

Main Results:

  • Consistent beneficial effects of aerosolized ribavirin were observed across all five studies.
  • The observed effects were both statistically significant and clinically relevant.
  • Oximetry and illness severity scales proved to be reliable outcome measures.

Conclusions:

  • Aerosolized ribavirin demonstrates a beneficial effect in managing RSV lower respiratory infection in infants.
  • The findings support the use of oximetry and illness severity scales in future multicenter studies.
  • Further research is warranted to explore ribavirin's role in severe cases and long-term outcomes.